Cytosorbents Corporation Share Price
Stocks
CTSO
US23283X2062
Advanced Medical Equipment & Technology
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3502 USD | -2.72% |
|
-7.87% | -45.21% |
| 05-13 | Cytosorbents Corporation, Q1 2026 Earnings Call, May 13, 2026 | |
| 05-13 | Cytosorbents Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 22.61M 19.87M 18.5M 16.99M 31.9M 2.17B 32.32M 220M 85.88M 1.07B 84.86M 83.03M 3.7B | P/E 2026 * |
-1.95x | P/E 2027 * | 12x |
|---|---|---|---|---|---|
| Enterprise Value | 22.61M 19.87M 18.5M 16.99M 31.9M 2.17B 32.32M 220M 85.88M 1.07B 84.86M 83.03M 3.7B | EV / Sales 2026 * |
0.59x | EV / Sales 2027 * | 0.48x |
| Free-Float |
84.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Cytosorbents Corporation
| 1 day | -2.72% | ||
| 1 week | -7.87% | ||
| Current month | -6.36% | ||
| 1 month | -8.25% | ||
| 3 months | -42.78% | ||
| 6 months | -48.27% | ||
| Current year | -45.21% |
| 1 week | 0.35 |  | 0.4 |
| 1 month | 0.35 | | 0.46 |
| Current year | 0.35 | | 0.84 |
| 1 year | 0.35 | | 1.22 |
| 3 years | 0.35 | | 3.8 |
| 5 years | 0.35 | | 9.8 |
| 10 years | 0.35 | | 14.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Phillip Chan
CEO | Chief Executive Officer | 55 | 23/07/2008 |
Peter Mariani
DFI | Director of Finance/CFO | 62 | 13/08/2024 |
Vincent Capponi
PSD | President | 68 | 27/04/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Edward Jones
BRD | Director/Board Member | 77 | 24/07/2011 |
Phillip Chan
BRD | Director/Board Member | 55 | 31/12/2008 |
Alan Sobel
BRD | Director/Board Member | 65 | 12/11/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 15/06/26 | Buy | Chief Executive Officer | 10,333 | 0.0165% | ||
| 15/06/26 | Buy | Chief Financial Officer | 100,000 | 0.1592% | ||
| 18/11/25 | Free | Chief Executive Officer | 100,000 | 0.1593% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.72% | -7.87% | -62.82% | -90.54% | 22.61M | |
| -1.01% | +6.93% | +16.03% | +0.48% | 211B | |
| +1.37% | -3.16% | -4.04% | -23.71% | 135B | |
| +6.28% | +1.57% | -27.38% | +10.87% | 119B | |
| +4.51% | +5.44% | -56.40% | -12.33% | 65.77B | |
| +0.86% | -1.84% | +6.31% | +0.93% | 47.58B | |
| +1.43% | +0.59% | -25.72% | -33.53% | 44.44B | |
| -0.49% | +6.00% | +15.51% | +9.02% | 39.14B | |
| -1.32% | +3.75% | +22.68% | +30.06% | 36.79B | |
| -2.18% | +3.08% | +73.25% | +0.35% | 29.37B | |
| Average | +0.68% | +0.60% | -4.26% | -10.84% | 72.81B | |
| Weighted average by Cap. | +1.36% | +0.78% | -1.90% | -3.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 38.26M 33.64M 31.31M 28.76M 54M 3.67B 54.71M 372M 145M 1.81B 144M 141M 6.26B | 47.12M 41.43M 38.56M 35.41M 66.5M 4.52B 67.38M 458M 179M 2.23B 177M 173M 7.71B |
| Net income | -11.74M -10.32M -9.61M -8.82M -16.57M -1.13B -16.79M -114M -44.6M -556M -44.07M -43.12M -1.92B | 2.37M 2.09M 1.94M 1.78M 3.35M 228M 3.39M 23.08M 9.02M 112M 8.91M 8.72M 388M |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/07/26 | US$0.3502 | -2.72% | 17,174 |
| 24/07/26 | US$0.3600 | -0.39% | 37,860 |
| 23/07/26 | US$0.3614 | -5.37% | 38,135 |
| 22/07/26 | US$0.3819 | -2.97% | 32,263 |
| 21/07/26 | US$0.3936 | +3.55% | 39,384 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CTSO Stock
Select your edition
All financial news and data tailored to specific country editions
